Clinical Trial Update: MINIALO-VELCADE2005: A Study of Bortezomib (Velcade) Treated Multiple Myeloma Patients Pre and Post Allogeneic Haematopoietic Progenitor Cell Transplant With no Myeloablative Conditioning [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating bortezomib (Velcade) in multiple myeloma patients before and after an allogeneic hematopoietic progenitor cell transplant without mye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED